Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1995 Dec;74(6):636–640. doi: 10.1136/hrt.74.6.636

Effect of low dose sotalol on the signal averaged P wave in patients with paroxysmal atrial fibrillation.

P J Stafford 1, J Cooper 1, D P de Bono 1, R Vincent 1, C J Garratt 1
PMCID: PMC484120  PMID: 8541169

Abstract

OBJECTIVE--To investigate the effects of low dose sotalol on the signal averaged surface P wave in patients with paroxysmal atrial fibrillation. DESIGN--A longitudinal within patient crossover study. SETTING--Cardiac departments of a regional cardiothoracic centre and a district general hospital. PATIENTS--Sixteen patients with documented paroxysmal atrial fibrillation. The median (range) age of the patients was 65.5 (36-70) years; 11 were men. MAIN OUTCOME MEASURES--Analysis of the signal averaged P wave recorded from patients not receiving antiarrhythmic medication and after 4-6 weeks' treatment with sotalol. P wave limits were defined automatically by a computer algorithm. Filtered P wave duration and energies contained in frequency bands from 20, 30, 40, 60, and 80 to 150 Hz of the P wave spectrum expressed as absolute values (P20, P30, etc) and as ratios of high to low frequency energy (PR20, PR30, etc) were measured. RESULTS--No difference in P wave duration was observed between the groups studied (mean (SEM) 149 (4) without medication and 152 (3) ms with sotalol). Significant decreases in high frequency P wave energy (for example P60: 4.3 (0.4) v 3.3 (0.3) microV2.s, P = 0.003) and energy ratio (PR60: 5.6 (0.5) v 4.7 (0.6), P = 0.03) were observed during sotalol treatment. These changes were independent of heart rate. CONCLUSIONS--Treatment with low dose sotalol reduces high frequency P wave energy but does not change P wave duration. These results are consistent with the class III effect of the drug and suggest that signal averaging of the surface P wave may be a useful non-invasive measure of drug induced changes in atrial electrophysiology.

Full text

PDF
636

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baciarello G., Bella R., Di Maio F., Sgrigna V., Villani M., Campbell S. V., Sciacca A. Analysis of high-resolution atrial activation: report on 403 cases. Am Heart J. 1987 Feb;113(2 Pt 1):307–315. doi: 10.1016/0002-8703(87)90270-5. [DOI] [PubMed] [Google Scholar]
  2. Bennett D. H. Acute prolongation of myocardial refractoriness by sotalol. Br Heart J. 1982 Jun;47(6):521–526. doi: 10.1136/hrt.47.6.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Buxton A. E., Waxman H. L., Marchlinski F. E., Josephson M. E. Atrial conduction: effects of extrastimuli with and without atrial dysrhythmias. Am J Cardiol. 1984 Oct 1;54(7):755–761. doi: 10.1016/s0002-9149(84)80203-9. [DOI] [PubMed] [Google Scholar]
  4. Cobbe S. M., Hoffman E., Ritzenhoff A., Brachmann J., Kübler W., Senges J. Action of sotalol on potential reentrant pathways and ventricular tachyarrhythmias in conscious dogs in the late postmyocardial infarction phase. Circulation. 1983 Oct;68(4):865–871. doi: 10.1161/01.cir.68.4.865. [DOI] [PubMed] [Google Scholar]
  5. Cosio F. G., Palacios J., Vidal J. M., Cocina E. G., Gómez-Sánchez M. A., Tamargo L. Electrophysiologic studies in atrial fibrillation. Slow conduction of premature impulses: a possible manifestation of the background for reentry. Am J Cardiol. 1983 Jan 1;51(1):122–130. doi: 10.1016/s0002-9149(83)80022-8. [DOI] [PubMed] [Google Scholar]
  6. David D., Naito M., Michelson E., Watanabe Y., Chen C. C., Morganroth J., Shaffenburg M., Blenko T. Intramyocardial conduction: a major determinant of R-wave amplitude during acute myocardial ischemia. Circulation. 1982 Jan;65(1):161–167. doi: 10.1161/01.cir.65.1.161. [DOI] [PubMed] [Google Scholar]
  7. Echt D. S., Berte L. E., Clusin W. T., Samuelsson R. G., Harrison D. C., Mason J. W. Prolongation of the human cardiac monophasic action potential by sotalol. Am J Cardiol. 1982 Nov;50(5):1082–1086. doi: 10.1016/0002-9149(82)90421-0. [DOI] [PubMed] [Google Scholar]
  8. Engel T. R., Vallone N., Windle J. Signal-averaged electrocardiograms in patients with atrial fibrillation or flutter. Am Heart J. 1988 Mar;115(3):592–597. doi: 10.1016/0002-8703(88)90809-5. [DOI] [PubMed] [Google Scholar]
  9. Freedman R. A., Karagounis L. A., Steinberg J. S. Effects of sotalol on the signal-averaged electrocardiogram in patients with sustained ventricular tachycardia: relation to suppression of inducibility and changes in tachycardia cycle length. J Am Coll Cardiol. 1992 Nov 1;20(5):1213–1219. doi: 10.1016/0735-1097(92)90380-6. [DOI] [PubMed] [Google Scholar]
  10. Funck-Brentano C., Kibleur Y., Le Coz F., Poirier J. M., Mallet A., Jaillon P. Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans. Circulation. 1991 Feb;83(2):536–545. doi: 10.1161/01.cir.83.2.536. [DOI] [PubMed] [Google Scholar]
  11. Hayward R. P., Taggart P. Effect of sotalol on human atrial action potential duration and refractoriness: cycle length dependency of class III activity. Cardiovasc Res. 1986 Feb;20(2):100–107. doi: 10.1093/cvr/20.2.100. [DOI] [PubMed] [Google Scholar]
  12. Kawano S., Hiraoka M., Sawanobori T. Electrocardiographic features of P waves from patients with transient atrial fibrillation. Jpn Heart J. 1988 Jan;29(1):57–67. doi: 10.1536/ihj.29.57. [DOI] [PubMed] [Google Scholar]
  13. Kunze K. P., Schlüter M., Kuck K. H. Sotalol in patients with Wolff-Parkinson-White syndrome. Circulation. 1987 May;75(5):1050–1057. doi: 10.1161/01.cir.75.5.1050. [DOI] [PubMed] [Google Scholar]
  14. Leier C. V., Meacham J. A., Schaal S. F. Prolonged atrial conduction. A major predisposing factor for the development of atrial flutter. Circulation. 1978 Feb;57(2):213–216. doi: 10.1161/01.cir.57.2.213. [DOI] [PubMed] [Google Scholar]
  15. Opolski G., Stanisławska J., Słomka K., Kraska T. Value of the atrial signal-averaged electrocardiogram in identifying patients with paroxysmal atrial fibrillation. Int J Cardiol. 1991 Mar;30(3):315–319. doi: 10.1016/0167-5273(91)90009-e. [DOI] [PubMed] [Google Scholar]
  16. Piccolo E., Raviele A., Delise P., Dainese F., Pascotto P., Totaro G., Sartori F., D'Este D. The role of left ventricular conduction in the electrogenesis of left ventricular hypertrophy. An electrophysiologic study in man. Circulation. 1979 May;59(5):1044–1055. doi: 10.1161/01.cir.59.5.1044. [DOI] [PubMed] [Google Scholar]
  17. Stafford P. J., Robinson D., Vincent R. Optimal analysis of the signal averaged P wave in patients with paroxysmal atrial fibrillation. Br Heart J. 1995 Oct;74(4):413–418. doi: 10.1136/hrt.74.4.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Stafford P. J., Turner I., Vincent R. Quantitative analysis of signal-averaged P waves in idiopathic paroxysmal atrial fibrillation. Am J Cardiol. 1991 Sep 15;68(8):751–755. doi: 10.1016/0002-9149(91)90648-5. [DOI] [PubMed] [Google Scholar]
  19. Stafford P., Denbigh P., Vincent R. Frequency analysis of the P wave: comparative techniques. Pacing Clin Electrophysiol. 1995 Feb;18(2):261–270. doi: 10.1111/j.1540-8159.1995.tb02516.x. [DOI] [PubMed] [Google Scholar]
  20. Strauss H. C., Bigger J. T., Jr, Hoffman B. F. Electrophysiologial and beta-receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue. Circ Res. 1970 Jun;26(6):661–678. doi: 10.1161/01.res.26.6.661. [DOI] [PubMed] [Google Scholar]
  21. Wang T., Bergstrand R. H., Thompson K. A., Siddoway L. A., Duff H. J., Woosley R. L., Roden D. M. Concentration-dependent pharmacologic properties of sotalol. Am J Cardiol. 1986 May 1;57(13):1160–1165. doi: 10.1016/0002-9149(86)90692-2. [DOI] [PubMed] [Google Scholar]
  22. Yamada T., Fukunami M., Ohmori M., Kumagai K., Sakai A., Kondoh N., Minamino T., Hoki N. Characteristics of frequency content of atrial signal-averaged electrocardiograms during sinus rhythm in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol. 1992 Mar 1;19(3):559–563. doi: 10.1016/s0735-1097(10)80273-6. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES